One company that should be on your radar is Kamada Ltd. (KMDA). The stock of this biopharmaceutical company has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Buy.
A key reason for this move has been the positive trend in the earnings estimate revisions picture. For KMDA’s full year estimate, we have seen 1 estimates go higher in the past 30 days, compared to no downward revision. This trend has helped the consensus estimate to trend higher, going from 6 cents a share a month ago to its current level at 8 cents.
This positive shift in estimates has made some investors take notice and buy the stock. In fact, KMDA has seen some pretty solid trading lately, as the company has moved higher by 11.8% in the past month.
If Kamada can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put KMDA on your watch list for the future.
Other top-ranked stocks worth considering in this space include Alexion Pharmaceuticals, Inc. (ALXN), Alkermes plc (ALKS) and Emergent BioSolutions, Inc. (EBS). All three carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
KAMADA LTD ORD (KMDA): Free Stock Analysis Report
EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
ALKERMES PLC ORD (ALKS): Free Stock Analysis Report
Zacks Investment Research